Nilutamide Tablet — FDA Drug Shortage
The FDA lists a drug shortage record for Nilutamide Tablet (tablet) from Advanz Pharma (US) Corp. with status To Be Discontinued. The shortage was first posted on 12/01/2025.
Shortage Details
- Status
- To Be Discontinued
- Company
- Advanz Pharma (US) Corp.
- Package NDC
- 66993-212-38
- Dosage Form
- Tablet
- Presentation
- Nilandron, Tablet, 150 mg (NDC 66993-212-38)
- Initial Posting
- 12/01/2025
- Revised Date